ReviewFrontiers in cardiovascular medicine2021

Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism.

Xiao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.